126 related articles for article (PubMed ID: 10925967)
1. Long-term follow-up of intestinal metaplasia of the gastric cardia.
Morales TG; Camargo E; Bhattacharyya A; Sampliner RE
Am J Gastroenterol; 2000 Jul; 95(7):1677-80. PubMed ID: 10925967
[TBL] [Abstract][Full Text] [Related]
2. Detection of cardia intestinal metaplasia: do the biopsy number and location matter?
Sharma P; McElhinney C; Topalovski M; Mayo MS; McGregor DH; Weston A
Am J Gastroenterol; 2004 Dec; 99(12):2424-8. PubMed ID: 15571591
[TBL] [Abstract][Full Text] [Related]
3. Intestinal metaplasia of the gastric cardia.
Morales TG; Sampliner RE; Bhattacharyya A
Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
[TBL] [Abstract][Full Text] [Related]
4. Intestinal metaplasia of the gastric cardia: a study from Turkey.
Dinçer D; Besisik F; Sahin E; Demir K; Tuncer I; Cevikbas U; Mungan Z; Kaymakoglu S; Boztas G; Ozdil S; Cakaloglu Y; Okten A
Hepatogastroenterology; 2002; 49(46):1153-6. PubMed ID: 12143225
[TBL] [Abstract][Full Text] [Related]
5. Correlation between intestinal metaplasia of the gastric cardia and gastroesophageal reflux disease.
Lanzafame S; Torrisi A; Favara C; Russo V; Emmanuele C
Hepatogastroenterology; 2001; 48(40):1007-10. PubMed ID: 11490786
[TBL] [Abstract][Full Text] [Related]
6. Gastric cardia intestinal metaplasia: biopsy follow-up of 85 patients.
Goldstein NS
Mod Pathol; 2000 Oct; 13(10):1072-9. PubMed ID: 11048800
[TBL] [Abstract][Full Text] [Related]
7. Intestinal metaplasia of the gastric cardia: A prospective study with enhanced magnification endoscopy.
Guelrud M; Herrera I; Essenfeld H; Castro J; Antonioli DA
Am J Gastroenterol; 2002 Mar; 97(3):584-9. PubMed ID: 11922550
[TBL] [Abstract][Full Text] [Related]
8. A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients.
Ojetti V; Persiani R; Nista EC; Rausei S; Lecca G; Migneco A; Cananzi FC; Cammarota G; D'Ugo D; Gasbarrini G; Gasbarrini A
Eur Rev Med Pharmacol Sci; 2007; 11(5):291-6. PubMed ID: 18074937
[TBL] [Abstract][Full Text] [Related]
9. Regression of intestinal metaplasia to cardiac or fundic mucosa in patients with Barrett's esophagus submitted to vagotomy, partial gastrectomy and duodenal diversion. A prospective study of 78 patients with more than 5 years of follow up.
Csendes A; Bragheto I; Burdiles P; Smok G; Henriquez A; Parada F
Surgery; 2006 Jan; 139(1):46-53. PubMed ID: 16364717
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication dramatically improves inflammation in the gastric cardia.
Sharma P; Topalovski M; Mayo MS; Sampliner RE; Weston AP
Am J Gastroenterol; 2000 Nov; 95(11):3107-11. PubMed ID: 11095325
[TBL] [Abstract][Full Text] [Related]
11. Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia.
Morales TG; Bhattacharyya A; Camargo E; Johnson C; Sampliner RE
Gastrointest Endosc; 1998 Jul; 48(1):26-31. PubMed ID: 9684660
[TBL] [Abstract][Full Text] [Related]
12. Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.
Harrison R; Perry I; Haddadin W; McDonald S; Bryan R; Abrams K; Sampliner R; Talley NJ; Moayyedi P; Jankowski JA
Am J Gastroenterol; 2007 Jun; 102(6):1154-61. PubMed ID: 17433019
[TBL] [Abstract][Full Text] [Related]
13. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa.
Goldblum JR; Richter JE; Vaezi M; Falk GW; Rice TW; Peek RM
Am J Gastroenterol; 2002 Feb; 97(2):302-11. PubMed ID: 11866266
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and distribution of gastric intestinal metaplasia and its subtypes.
Eriksson NK; Kärkkäinen PA; Färkkilä MA; Arkkila PE
Dig Liver Dis; 2008 May; 40(5):355-60. PubMed ID: 18291729
[TBL] [Abstract][Full Text] [Related]
19. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
[TBL] [Abstract][Full Text] [Related]
20. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
